NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
基本信息
- 批准号:10310637
- 负责人:
- 金额:$ 416.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAcuteAddressAdverse effectsAffectAlzheimer&aposs disease related dementiaAmericanBypassCOVID-19COVID-19 pandemicCOVID-19 vaccineCaringCenters for Disease Control and Prevention (U.S.)Cessation of lifeClinicalCognitiveCollaborationsCommunitiesComplexComputerized Medical RecordConsumptionDataData LinkagesData ReportingDatabasesDisease OutbreaksElderlyElectronic Health RecordEngineeringEnvironmentFrail ElderlyFutureGeographyHealth systemHealthcareHealthcare SystemsIncidenceIndividualInfectionInterventionInvestigationLong-Term CareMedicalMedicareMedicare claimMinorityModelingMonitorMorbidity - disease rateNursing HomesOutcomePoliciesPolicy MakerPopulationPrevalenceProviderPublic HealthPublicationsRecordsResearchResearch PersonnelResourcesRiskSecureSeveritiesSkilled Nursing FacilitiesSourceStandardizationStructureSubgroupSymptomsSystemTechnologyTestingTimeTouch sensationUnited States Centers for Medicare and Medicaid ServicesUpdateVaccinatedVaccinationVaccine Clinical TrialVariantVendorVirusbasecare deliverycollaboratorycommunecoronavirus diseasecostdata infrastructuredata integrationdata sharingdata structureethnic minority populationexperiencefunctional declineinsightmortalityoperationpandemic diseasepaymentpragmatic trialprocess repeatabilitypublic health emergencyracial minorityresponsescreeningsurveillance datasurveillance studysystems researchtransmission processtrend
项目摘要
ABSTRACT
The Coronavirus Disease 2019 (COVID) pandemic has disproportionately affected long-term care residents
in the US, who currently represent 7% of cases nationwide, but 40% of deaths. As of late November, over
100,000 residents have died, but incomplete data means these are undercounts. Skilled nursing facilities
(SNFs) provide a mix of post-acute and long-term care to medically-complex older adults, about 70% of whom
have Alzheimer’s Disease and Related Dementias (ADRD) and are particularly vulnerable to SARS-CoV-2.
SARS-CoV-2 represents the most serious challenge to SNFs in decades because of its lethality and ease of
transmission, especially by asymptomatic carriers. A major barrier to developing appropriate clinical and
operational responses to mitigate the pandemic’s effects is the lack of comprehensive data. While the Centers
for Medicare & Medicaid Services (CMS) and the Centers for Disease Control and Prevention (CDC) created
data reporting systems, these facility-level data are insufficient to understand which residents acquire COVID
or resident-level clinical outcomes. The current surveillance data offer no insight into predictors of mortality or
whether these predictors have changed as the case fatality has declined since Spring of 2020.To truly
understand the national impact of COVID (and similar future public health threats), a much larger, richer, and
nationally representative database of SNFs is needed. This database is particularly important since residents
will be vaccinated for COVID with little information on adverse effects that frail older adults may experience at
higher rates or greater severity than the populations that were included in the clinical trials for these vaccines .
Working with the American Health Care Association (AHCA) and two technology partners, this supplement
to the IMPACT Collaboratory [U54 AG063546] will: 1) assemble an integrated database of detailed, electronic
medical records data from some 10,000 US nursing homes and then merge these records with Medicare
claims, creating a regularly updated data infrastructure to address clinical and policy questions pertaining to
COVID (but which could apply to future conditions) such as: 2) What is the cumulative incidence of COVID
among racial minorities and residents with ADRD?; 3) What influence do demographic, clinical, organizational,
and regional factors have on nursing home residents’ risk of morbidity and mortality from COVID?; 4) Which
nursing home residents are vaccinated against COVID and are those with ADRD and/or minorities less likely to
be vaccinated?; and 5) Have the rates of physical and cognitive functional decline increased between 2019
and 2020 among residents living with ADRD, independent of COVID infection? This data infrastructure will
revolutionize the rapid monitoring of nursing home trends in new infections and treatments and create a large,
detailed database for quantifying the direct and indirect effects of federal and state policy changes.
摘要
冠状病毒2019年(COVID)大流行对长期护理居民的影响不成比例
在美国,世卫组织目前占全国病例的7%,但占死亡人数的40%。截至11月下旬,完毕
已有10万居民死亡,但不完整的数据意味着这些都是被低估的。熟练的护理设施
(SNF)为医疗复杂的老年人提供急性后护理和长期护理的组合,其中约70%
患有阿尔茨海默氏症和相关痴呆症(ADRD),特别容易感染SARS-CoV-2。
SARS-CoV-2是几十年来对SNF最严峻的挑战,因为它的致命性和易感性
传播性传播,尤指无症状携带者。开发适当的临床和医疗保健服务的主要障碍
减轻大流行影响的业务对策是缺乏全面的数据。而这些中心
为Medicare&Medicaid Services(CMS)和疾病控制和预防中心(CDC)创建
数据报告系统,这些设施级别的数据不足以了解哪些居民感染了COVID
或住院医生水平的临床结果。目前的监测数据没有提供对死亡率或
自2020年春季以来,随着病死率下降,这些预测因素是否发生了变化
了解COVID(以及类似的未来公共卫生威胁)对国家的影响,一个更大、更丰富、更
需要具有全国代表性的SNF数据库。这个数据库特别重要,因为居民
将接种COVID疫苗,几乎没有关于虚弱老年人可能在
比这些疫苗的临床试验中包括的人群更高的发病率或更严重的病情。
与美国医疗保健协会(AHCA)和两个技术合作伙伴合作,本增刊
到Impact合作实验室[U54 AG063546]将:1)建立一个详细的、电子的综合数据库
美国大约10,000家疗养院的医疗记录数据,然后将这些记录与联邦医疗保险合并
创建定期更新的数据基础架构,以解决与以下相关的临床和政策问题
COVID(但可能适用于未来的情况),例如:2)COVID的累积发病率是多少
在少数族裔和患有ADRD的居民中?3)人口,临床,组织,
以及地区因素对养老院居民患COVID的发病率和死亡率的风险?4)
疗养院居民接种了COVID疫苗,患有ADRD和/或少数民族的人不太可能
接种疫苗吗?5)2019年之间身体和认知功能衰退的比率是否有所增加
和2020年感染ADRD的居民中,与COVID感染无关的?此数据基础架构将
彻底改变对疗养院新感染和治疗趋势的快速监测,并创造一个
详细的数据库,用于量化联邦和州政策变化的直接和间接影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUSAN L MITCHELL其他文献
SUSAN L MITCHELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUSAN L MITCHELL', 18)}}的其他基金
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10183561 - 财政年份:2019
- 资助金额:
$ 416.9万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10005976 - 财政年份:2019
- 资助金额:
$ 416.9万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10229425 - 财政年份:2019
- 资助金额:
$ 416.9万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10285112 - 财政年份:2019
- 资助金额:
$ 416.9万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10358216 - 财政年份:2019
- 资助金额:
$ 416.9万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10183547 - 财政年份:2019
- 资助金额:
$ 416.9万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10443662 - 财政年份:2019
- 资助金额:
$ 416.9万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10308958 - 财政年份:2019
- 资助金额:
$ 416.9万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10670536 - 财政年份:2019
- 资助金额:
$ 416.9万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10673655 - 财政年份:2019
- 资助金额:
$ 416.9万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 416.9万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 416.9万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 416.9万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 416.9万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 416.9万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 416.9万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 416.9万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 416.9万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 416.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 416.9万 - 项目类别:
Operating Grants